Proof of concept provides pathway to address problem of substandard and falsified drugs
Over the last 10 months we’ve been busy working with our partners in the Lieberman Lab at the University of Notre Dame…
Category: Pharma
The latest news on ARTiFACTS Verify
It’s been a little while since we’ve given you an update on what’s happening with ARTiFACTS Verify – and that’s because it’s…
Challenges Of Supply Vs Demand In The US Pharmaceutical Supply Chain
The United States faces numerous challenges when it comes to balancing supply v demand in the pharmaceutical supply chain. The intricate nature…
Cisplatin in the US – key differences in drug regulation between US FDA and the Chinese NMPA
Recently, the US Food and Drug Administration (FDA) took the uncommon step of allowing temporary imports of a chemotherapy drug to ease…
The cost of substandard or falsified chemotherapy drugs in LMICs – and what we’re doing to help
Cancer is one of the leading causes of death worldwide, and the use of chemotherapy drugs is a critical component of cancer…
How the ARTiFACTS and Notre Dame collaboration addresses substandard or falsified drugs in pharmaceutical supply chains, a global public health challenge
Today, virtually every country is impacted by substandard or falsified drugs entering their system, from generics to more expensive treatments for cancer…
4 Critical Challenges Facing Pharma Supply Chains
The pharmaceutical industry plays a pivotal role in safeguarding public health by ensuring the timely and reliable distribution of life-saving medications worldwide….